Think saying um and uh makes you sound unprepared? These tiny hesitation words play an important role in how we think, speak, and communicate.

And Schafmeister isn’t the only chemist turning to modular methods of synthesis to explore vast regions of chemical space. It ...

AbbVie’s $10.9B Apogee deal strengthens immunology beyond Humira, adds Zumilokibart optionality, and may be undervalued. See ...

Doctors have few options for patients who develop a life-threatening lung condition called acute respiratory distress syndrome, or ARDS. A frequent cause of death during the COVID-19 pandemic, ARDS ...

Scientists have cracked how bacteria build cancer-fighting compounds, a breakthrough that could speed up new treatments. The ...

RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...

Can the mix really help with premenstrual woes? Theoretically, the link between histamine and hormones could explain why the ...

I hit the buy button on AbbVie (NYSE:ABBV | ABBV Price Prediction) again last week, and I will hit it again the next time June’s macro noise hands me a discount. While short-term traders chase ...

On June 22, Wells Fargo maintained an Overweight rating on AbbVie Inc. (NYSE:ABBV). It also set a $260 price target on the ...

For the 18 million people living with rheumatoid arthritis, disease management currently means a lifetime of injections-a ...

Apogee Therapeutics is developing a promising atopic dermatitis drug.

AbbVie is close to finalizing a $10.9 billion cash acquisition of Apogee Therapeutics (APGE) The proposed price represents approximately 60% above Apogee’s June 18 share price of $90.38 JPMorgan ...